Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 1
2023 2
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Relationship between nephrotoxicity and area under the concentration-time curve of vancomycin in critically ill patients: a multicenter retrospective study.
Ishigo T, Matsumoto K, Yoshida H, Tanaka H, Ibe Y, Fujii S, Fukudo M, Fujihara H, Yamaguchi F, Ebihara F, Maruyama T, Hamada Y, Samura M, Nagumoi F, Komatsu T, Tomizawa A, Takuma A, Chiba H, Nishi Y, Enoki Y, Taguchi K, Suzuki A. Ishigo T, et al. Microbiol Spectr. 2024 Jul 2;12(7):e0373923. doi: 10.1128/spectrum.03739-23. Epub 2024 May 22. Microbiol Spectr. 2024. PMID: 38775483 Free PMC article.
In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitals.
Kimbrough JH, Maher JM, Sader HS, Castanheira M, Mendes RE. Kimbrough JH, et al. Microbiol Spectr. 2024 Nov 5;12(11):e0147424. doi: 10.1128/spectrum.01474-24. Epub 2024 Oct 10. Microbiol Spectr. 2024. PMID: 39387599 Free PMC article.
Variability of macrolide-resistant profile in Mycobacterium avium complex pulmonary disease.
Fukushima K, Matsumoto Y, Abe Y, Hashimoto K, Motooka D, Kitada S, Saito H, Komukai S, Fukui E, Niitsu T, Nabeshima H, Nagahama Y, Yamauchi J, Nitta T, Nii T, Matsuki T, Tsujino K, Miki K, Shintani Y, Kumanogoh A, Akira S, Nakamura S, Kida H. Fukushima K, et al. Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0121324. doi: 10.1128/aac.01213-24. Epub 2024 Oct 8. Antimicrob Agents Chemother. 2024. PMID: 39377582 Free PMC article.
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study.
Nagane M, Ichimura K, Onuki R, Narushima D, Honda-Kitahara M, Satomi K, Tomiyama A, Arai Y, Shibata T, Narita Y, Uzuka T, Nakamura H, Nakada M, Arakawa Y, Ohnishi T, Mukasa A, Tanaka S, Wakabayashi T, Aoki T, Aoki S, Shibui S, Matsutani M, Ishizawa K, Yokoo H, Suzuki H, Morita S, Kato M, Nishikawa R. Nagane M, et al. Cancers (Basel). 2022 Nov 10;14(22):5522. doi: 10.3390/cancers14225522. Cancers (Basel). 2022. PMID: 36428615 Free PMC article.